{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:10:38Z","timestamp":1789686638464,"version":"4.0.1"},"reference-count":25,"publisher":"e-Century Publishing Corporation","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/qibf6088","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T04:21:39Z","timestamp":1737519699000},"page":"221-229","source":"Crossref","is-referenced-by-count":2,"title":["Study on the expression of S100A4 and HMGA1 in endometrial carcinoma and their correlation with metastasis"],"prefix":"10.62347","volume":"17","author":[{"given":"Xiaohui","family":"Pei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","unstructured":"Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, Ledermann J, Bosse T, Chargari C, Fagotti A, Fotopoulou C, Gonzalez Martin A, Lax S, Lorusso D, Marth C, Morice P, Nout RA, O&#x2019;Donnell D, Querleu D, Raspollini MR, Sehouli J, Sturdza A, Taylor A, Westermann A, Wimberger P, Colombo N, Planchamp F and Creutzberg CL. ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer 2021; 31: 12-39.","journal-title":"Int J Gynecol Cancer"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12885-024-12090-3","article-title":"Clinical characteristics and radiation therapy modality of younger patients with early-stage endometrial cancer, a multicenter study in China&#x2019;s real world","volume":"24","author":"Zhang","year":"2024","unstructured":"Zhang K, Wang T, Liu Z, He J, Sun X, Zhong W, Zhao F, Li X, Li S, Zhu H, Ma Z, Hu K, Zhang F, Hou X, Wei L and Zou L. Clinical characteristics and radiation therapy modality of younger patients with early-stage endometrial cancer, a multicenter study in China&#x2019;s real world. BMC Cancer 2024; 24: 360.","journal-title":"BMC Cancer"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2478\/raon-2021-0009","article-title":"Surgical treatment and fertility perservation in endometrial cancer","volume":"55","author":"Kovacevic","year":"2021","unstructured":"Kovacevic N. Surgical treatment and fertility perservation in endometrial cancer. Radiol Oncol 2021; 55: 144-149.","journal-title":"Radiol Oncol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"19280","DOI":"10.1002\/jcp.28607","article-title":"The potential role of miR-29 in health and cancer diagnosis, prognosis, and therapy","volume":"234","author":"Alizadeh","year":"2019","unstructured":"Alizadeh M, Safarzadeh A, Beyranvand F, Ahmadpour F, Hajiasgharzadeh K, Baghbanzadeh A and Baradaran B. The potential role of miR-29 in health and cancer diagnosis, prognosis, and therapy. J Cell Physiol 2019; 234: 19280-19297.","journal-title":"J Cell Physiol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.7150\/ijbs.72952","article-title":"High mobility group A1 (HMGA1): structure, biological function, and therapeutic potential","volume":"18","author":"Wang","year":"2022","unstructured":"Wang L, Zhang J, Xia M, Liu C, Zu X and Zhong J. High mobility group A1 (HMGA1): structure, biological function, and therapeutic potential. Int J Biol Sci 2022; 18: 4414-4431.","journal-title":"Int J Biol Sci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.bbrc.2019.06.071","article-title":"HMGA1 promoting gastric cancer oncogenic and glycolytic phenotypes by regulating c-myc expression","volume":"516","author":"Cao","year":"2019","unstructured":"Cao XP, Cao Y, Zhao H, Yin J and Hou P. HMGA1 promoting gastric cancer oncogenic and glycolytic phenotypes by regulating c-myc expression. Biochem Biophys Res Commun 2019; 516: 457-465.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Liu S, Zhang H, Li Y, Zhang Y, Bian Y, Zeng Y, Yao X, Wan J, Chen X, Li J, Wang Z and Qin Z. S100A4 enhances protumor macrophage polarization by control of PPAR-gamma-dependent induction of fatty acid oxidation. J Immunother Cancer 2021; 9: e002548.","DOI":"10.1136\/jitc-2021-002548"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3389\/fonc.2019.01074","article-title":"Inhibition of CYR61-S100A4 axis limits breast cancer invasion","volume":"9","author":"Hellinger","year":"2019","unstructured":"Hellinger JW, Huchel S, Goetz L, Bauerschmitz G, Emons G and Grundker C. Inhibition of CYR61-S100A4 axis limits breast cancer invasion. Front Oncol 2019; 9: 1074.","journal-title":"Front Oncol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12957-019-1707-4","article-title":"9 levels in pancreatic carcinoma and its prognostic significance","volume":"17","author":"Jia","year":"2019","unstructured":"Jia F, Liu M, Li X, Zhang F, Yue S and Liu J. Relationship between S100A4 protein expression and pre-operative serum CA19.9 levels in pancreatic carcinoma and its prognostic significance. World J Surg Oncol 2019; 17: 163.","journal-title":"World J Surg Oncol"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Fendt BM, Hirschmann A, Bruns M, Camarillo-Retamosa E, Ospelt C and Vogetseder A. Protein atlas of fibroblast specific protein 1 (FSP1)\/S100A4. Histol Histopathol 2023; 38: 1391-1401.","DOI":"10.21203\/rs.3.rs-1579878\/v1"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/S0140-6736(22)00323-3","article-title":"Endometrial cancer","volume":"399","author":"Crosbie","year":"2022","unstructured":"Crosbie EJ, Kitson SJ, McAlpine JN, Mukhopadhyay A, Powell ME and Singh N. Endometrial cancer. Lancet 2022; 399: 1412-1428.","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1111\/1471-0528.17087","article-title":"Adult lifetime body mass index trajectories and endometrial cancer risk","volume":"129","author":"Dalmartello","year":"2022","unstructured":"Dalmartello M, Vermunt J, Negri E, Levi F and La Vecchia C. Adult lifetime body mass index trajectories and endometrial cancer risk. BJOG 2022; 129: 1521-1529.","journal-title":"BJOG"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1016\/j.csbj.2022.06.039","article-title":"Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers","volume":"20","author":"Wang","year":"2022","unstructured":"Wang N, Zhu L, Wang L, Shen Z and Huang X. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers. Comput Struct Biotechnol J 2022; 20: 3106-3119.","journal-title":"Comput Struct Biotechnol J"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41568-019-0177-x","article-title":"Clinical actionability of molecular targets in endometrial cancer","volume":"19","author":"Urick","year":"2019","unstructured":"Urick ME and Bell DW. Clinical actionability of molecular targets in endometrial cancer. Nat Rev Cancer 2019; 19: 510-521.","journal-title":"Nat Rev Cancer"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1056\/NEJMra1514010","article-title":"Endometrial cancer","volume":"383","author":"KH","year":"2020","unstructured":"Lu KH and Broaddus RR. Endometrial cancer. N Engl J Med 2020; 383: 2053-2064.","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"8755","DOI":"10.2174\/0929867328666210705144456","article-title":"Endometrial cancer: genetic, metabolic characteristics, therapeutic strategies and nanomedicine","volume":"28","author":"Cai","year":"2021","unstructured":"Cai Y, Wang B, Xu W, Liu K, Gao Y, Guo C, Chen J, Kamal MA and Yuan C. Endometrial cancer: genetic, metabolic characteristics, therapeutic strategies and nanomedicine. Curr Med Chem 2021; 28: 8755-8781.","journal-title":"Curr Med Chem"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.3390\/biom13071099","article-title":"Targeted destruction of S100A4 inhibits metastasis of triple negative breast cancer cells","volume":"13","author":"Ismail","year":"2023","unstructured":"Ismail TM, Crick RG, Du M, Shivkumar U, Carnell A, Barraclough R, Wang G, Cheng Z, Yu W, Platt-Higgins A, Nixon G and Rudland PS. Targeted destruction of S100A4 inhibits metastasis of triple negative breast cancer cells. Biomolecules 2023; 13: 1099.","journal-title":"Biomolecules"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1058337","DOI":"10.3389\/fonc.2023.1058337","article-title":"Angiogenesis regulators S100A4, SPARC and SPP1 correlate with macrophage infiltration and are prognostic biomarkers in colon and rectal cancers","volume":"13","author":"Kazakova","year":"2023","unstructured":"Kazakova E, Rakina M, Sudarskikh T, Iamshchikov P, Tarasova A, Tashireva L, Afanasiev S, Dobrodeev A, Zhuikova L, Cherdyntseva N, Kzhyshkowska J and Larionova I. Angiogenesis regulators S100A4, SPARC and SPP1 correlate with macrophage infiltration and are prognostic biomarkers in colon and rectal cancers. Front Oncol 2023; 13: 1058337.","journal-title":"Front Oncol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"4447","DOI":"10.1002\/tox.24351","article-title":"Long noncoding RNA VPS9D1-AS1 promotes the progression of endometrial cancer via regulation of the miR-187-3p\/S100A4 axis","volume":"39","author":"Ren","year":"2024","unstructured":"Ren W and Ouyang L. Long noncoding RNA VPS9D1-AS1 promotes the progression of endometrial cancer via regulation of the miR-187-3p\/S100A4 axis. Environ Toxicol 2024; 39: 4447-4458.","journal-title":"Environ Toxicol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41419-020-2356-9","article-title":"MYC-regulated pseudogene HMGA1P6 promotes ovarian cancer malignancy via augmenting the oncogenic HMGA1\/2","volume":"11","author":"Tian","year":"2020","unstructured":"Tian X, Song J, Zhang X, Yan M, Wang S, Wang Y, Xu L, Zhao L, Wei JJ, Shao C, Kong B and Liu Z. MYC-regulated pseudogene HMGA1P6 promotes ovarian cancer malignancy via augmenting the oncogenic HMGA1\/2. Cell Death Dis 2020; 11: 167.","journal-title":"Cell Death Dis"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"120268","DOI":"10.1016\/j.lfs.2021.120268","article-title":"miR-142-3p simultaneously targets HMGA1, HMGA2, HMGB1, and HMGB3 and inhibits tumorigenic properties and in-vivo metastatic potential of human cervical cancer cells","volume":"291","author":"Sharma","year":"2022","unstructured":"Sharma P, Yadav P, Jain RP, Bera AK and Karunagaran D. miR-142-3p simultaneously targets HMGA1, HMGA2, HMGB1, and HMGB3 and inhibits tumorigenic properties and in-vivo metastatic potential of human cervical cancer cells. Life Sci 2022; 291: 120268.","journal-title":"Life Sci"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10549-019-05419-1","article-title":"High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer","volume":"179","author":"Gorbounov","year":"2020","unstructured":"Gorbounov M, Carleton NM, Asch-Kendrick RJ, Xian L, Rooper L, Chia L, Cimino-Mathews A, Cope L, Meeker A, Stearns V, Veltri RW, Bae YK and Resar LMS. High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer. Breast Cancer Res Treat 2020; 179: 25-35.","journal-title":"Breast Cancer Res Treat"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1097\/PAS.0000000000001320","article-title":"Stromal p16 expression helps distinguish atypical polypoid adenomyoma from myoinvasive endometrioid carcinoma of the uterus","volume":"43","author":"Kihara","year":"2019","unstructured":"Kihara A, Amano Y, Yoshimoto T, Matsubara D, Fukushima N, Fujiwara H and Niki T. Stromal p16 expression helps distinguish atypical polypoid adenomyoma from myoinvasive endometrioid carcinoma of the uterus. Am J Surg Pathol 2019; 43: 1526-1535.","journal-title":"Am J Surg Pathol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/curroncol29010005","article-title":"HMGA1 has predictive value in response to chemotherapy in gastric cancer","volume":"29","author":"Padua","year":"2021","unstructured":"Padua D, Pinto DF, Figueira P, Pereira CF, Almeida R and Mesquita P. HMGA1 has predictive value in response to chemotherapy in gastric cancer. Curr Oncol 2021; 29: 56-67.","journal-title":"Curr Oncol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12885-021-07850-4","article-title":"The role of S100A4 for bone metastasis in prostate cancer cells","volume":"21","author":"Kim","year":"2021","unstructured":"Kim B, Jung S, Kim H, Kwon JO, Song MK, Kim MK, Kim HJ and Kim HH. The role of S100A4 for bone metastasis in prostate cancer cells. BMC Cancer 2021; 21: 137.","journal-title":"BMC Cancer"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/1\/ajtr0160115.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:56:01Z","timestamp":1766022961000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/1\/ajtr0160115.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/qibf6088","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}